Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deciphering the Worst Pattern of Invasion in Oral Cancer: Integrative Clinical, Pathological, and Multimodal Nonlinear Optical Imaging Insights.

Laboratory investigation; a journal of technical methods and pathology·2025
Same author

Age-Group Subanalyses in TriNetX: A Critique and Re-Analysis.

International forum of allergy & rhinology·2025
Same author

Comparing the 7th and 8th Editions of AJCC Staging System for Hypopharyngeal Cancer Undergoing Surgery.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2025
Same author

EpCAM-Targeted Erlotinib Delivery: Enhancing Nasopharyngeal Carcinoma Treatment With Polyethylene Glycol-Coated Graphene Oxide.

Head & neck·2025
Same author

Transcutaneous Laryngeal Ultrasound for Assessing Hyaluronic Acid Status in Patients Undergoing Injection Laryngoplasty.

The Laryngoscope·2024
Same author

Enhancing regional control in p16-negative oropharyngeal cancer: A propensity score-matched analysis of upfront neck dissection and definitive chemoradiotherapy.

Journal of the Chinese Medical Association : JCMA·2024

Related Experiment Video

Updated: Jun 20, 2026

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

Percutaneous corticosteroid injection for vocal fold polyp.

Yen-Bin Hsu1, Ming-Chin Lan, Shyue-Yih Chang

  • 1Department of Otolaryngology, Taipei Veterans General Hospital, National Yang-Ming University, No. 201 Section 2 Shih-Pai Road, Taipei 112, Taiwan.

Archives of Otolaryngology--Head & Neck Surgery
|August 19, 2009
PubMed
Summary

Percutaneous corticosteroid injection effectively treats vocal fold polyps with high remission rates and minimal complications. This minimally invasive procedure offers a safe and cost-effective alternative to traditional surgery.

More Related Videos

Subcutaneous Neurotrophin 4 Infusion Using Osmotic Pumps or Direct Muscular Injection Enhances Aging Rat Laryngeal Muscles
05:50

Subcutaneous Neurotrophin 4 Infusion Using Osmotic Pumps or Direct Muscular Injection Enhances Aging Rat Laryngeal Muscles

Published on: June 13, 2017

Related Experiment Videos

Last Updated: Jun 20, 2026

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

Subcutaneous Neurotrophin 4 Infusion Using Osmotic Pumps or Direct Muscular Injection Enhances Aging Rat Laryngeal Muscles
05:50

Subcutaneous Neurotrophin 4 Infusion Using Osmotic Pumps or Direct Muscular Injection Enhances Aging Rat Laryngeal Muscles

Published on: June 13, 2017

Area of Science:

  • Otolaryngology
  • Vocal fold pathology
  • Minimally invasive procedures

Background:

  • Vocal fold polyps can cause significant dysphonia.
  • Traditional treatments like microlaryngoscopic surgery carry risks and may require longer recovery.
  • There is a need for less invasive and equally effective treatment options.

Purpose of the Study:

  • To assess the effectiveness and applicability of percutaneous corticosteroid injection for vocal fold polyps.
  • To detail the advantages and limitations of this technique in managing vocal fold polyps.

Main Methods:

  • A prospective case series involving 24 patients with vocal fold polyps.
  • Percutaneous corticosteroid injection performed under topical anesthesia.
  • Postoperative evaluation using stroboscopy, GRBAS scale, Voice Handicap Index, and phonatory function tests.

Main Results:

  • Successful completion in 22/24 patients with no complications.
  • Overall response rate of 91% and complete remission in 59% of patients.
  • Significant improvements in dysphonia (GRBAS), voice quality (VHI), and objective phonatory measures (MPT, jitter, shimmer, NH ratio).

Conclusions:

  • Percutaneous corticosteroid injection is a viable and effective treatment for vocal fold polyps.
  • The procedure is minimally invasive with low morbidity.
  • It presents a simple, cost-effective alternative to microlaryngoscopic surgery.